Imaging providers are implementing new and creative ways to improve breast cancer screening at their facilities, including holding special V.I.P. nights and offering services from within a shopping mall.

The American Society for Radiation Oncology (ASTRO) is championing bipartisan legislation introduced Wednesday, June 5, that would reduce prior authorization practices found to delay patient access to necessary cancer treatments.

Half of all physicians in the United States experience burnout, and recent surveys have suggested that number could be even higher among women.

An updated cost-effectiveness analysis of evolocumab suggests that while treatment with the PCSK9 inhibitor may always be somewhat costly, it remains effective in hard-to-treat patients and its reduced list price meets cost-effectiveness thresholds across a range of CV events in patients with very-high-risk atherosclerotic CVD.

Drugmaker Pfizer hid that one of its powerful anti-inflammatory drugs for rheumatoid arthritis therapy, Enbrel, reduced the risk of Alzheimer’s disease by 64%, according to a report by the Washington Post.

The U.S. Securities and Exchange Commission (SEC) is investigating a handful of healthcare companies over potentially using intermediaries to set up bribes with Chinese government and hospital officials to sell medical equipment, according to reporting by Reuters.

The U.S. Pharmacopeia (USP) has published a new chapter on the minimum standards required to prepare, compound, dispense and repackage both sterile and non-sterile radiopharmaceuticals associated with state-licensed activities.

Partners HealthCare, a Boston-based health system, has backed out of its planned acquisition of Care New England